The FDA defied its own experts to approve a new prescription narcotic in a form almost certain to cause addiction and death from overdoses.
On October 26 the savvy investor’s website SeekingAlpha.com published the following remarkable comment about a new and highly addictive painkiller called Zohydro ER, which only the previous day had been approved for sale by the U.S. Food and Drug Administration despite consistent warnings – including from the FDA’s official advisory panel – that Z is potentially more addictive and dangerous than its sister opiate drug, the original and deadly OxyContin.
The full article can be read here:
Latest posts by Jeffrey Lynne (see all)
- Lawsuits Continue Against Insurance Companies for Refusing to Pay for Mental Health Care - November 21, 2018
- Why Isn’t Housing Deemed “Medically Necessary” in SUD Treatment? - November 15, 2018
- Federal Government Seeks to Commentary Relating to Anti-Kickback Laws - November 2, 2018